EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities

Jilong Cao, Gang Lv, Fang Wei iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1645 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Jilong Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Party Affairs and Administration Office, the Fourth Affiliated Hospital of China Medical University, Shenyang, P. R. China. Hauptthemen laut MEDLINE: Breast Neoplasms, Exosomes. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer remains a global health challenge, necessitating innovative therapeutic approaches. Immunomodulation and immunotherapy have emerged as promising strategies for breast cancer treatment. Engineered exosomes are the sort of exosomes modified with surface decoration and internal therapeutic molecules. Through suitable modifications, engineered exosomes exhibit the capability to overcome the limitations associated with traditional therapeutic approaches. This ability opens up novel avenues for the development of more effective, personalized, and minimally invasive interventions. Main body In this comprehensive review, we explore the molecular insights and therapeutic potential of engineered exosomes in breast cancer. We discuss the strategies employed for exosome engineering and delve into their molecular mechanisms in reshaping the immune microenvironment of breast cancer.

Conclusions

By elucidating the contribution of engineered exosomes to breast cancer immunomodulation, this review underscores the transformative potential of this emerging field for improving breast cancer therapy. Highlights Surface modification of exosomes can improve the targeting specificity. The engineered exosome‐loaded immunomodulatory cargo regulates the tumour immune microenvironment. Engineered exosomes are involved in the immune regulation of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsExosomesHumansFemaleImmunotherapyTumor MicroenvironmentCell Communication

Stichwörter der Autor:innen

breast cancerengineered exosomesimmune microenvironmentimmunomodulationimmunotherapy

Autor:innen und Institutionen

  • Party Affairs and Administration Office, the Fourth Affiliated Hospital of China Medical University, Shenyang, P. R. China.
  • Department of Thyroid and Breast Surgery, Chaohu Hospital of Anhui Medical University, Chaohu, P. R. China.
  • Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, P. R. China.

ORCID-Profile: Fang Wei

Zitieren

APA

Cao, J., Lv, G., & Wei, F. (2024). Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1645

Vancouver

Cao J, Lv G, Wei F. Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1645

BibTeX
@article{Cao2024,
  author = {Cao, Jilong and Lv, Gang and Wei, Fang},
  title = {Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1645}
}
Kostenlos starten →